Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Split-face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin

NCT04898582 is registered in ClinicalTrials.gov with Institute of Skin and Product Evaluation, Italy as lead sponsor.

NCT NCT04898582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Split-face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin
Lead sponsor
Institute of Skin and Product Evaluation, Italy
Phase
Not applicable
Overall status
Unknown status
Start date
May 18, 2021
Completion date
May 18, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea, sensitive skin